Correction to: Molecular Psychiatry (2004) 9, 1060–1061. doi:10.1038/sj.mp.4001561

Following the publication of the above paper, the author has identified errors in Figure 1. The correct Figure 1 is shown below. The synonymous mutation gene C957T in the human D2 dopamine receptor (DRD2) significantly affects striatal DRD2 availability in vivo. The data should indicate that the C957T polymorphism had a highly significant effect on DRD2 binding potential (BP) with highest BP in T/T, intermediate in C/T and lowest in C/C genotype. The result is not in line with the previous in vitro study (Duan J et al. Hum Mol Genet 2003; 12: 205–216) in which the T allele of the C957T polymorphism was associated with reduced mRNA stability and synthesis of the dopamine D2 receptor.

Figure 1
figure 1

C957T genotype affects striatal DRD2 binding potential: BP values were 3.08±0.17 (mean±SEM), 2.64±0.09 and 2.46±0.14 in T/T, C/T and C/C genotypes, respectively.